| Year |
Citation |
Score |
| 2019 |
Matsushita Y, Smith B, Delannoy M, Trujillo MA, Chianchiano P, McMillan R, Kamiyama H, Liang H, Thompson ED, Hruban RH, Matsui W, Wood LD, Roberts NJ, Eshleman JR. Biphenotypic Differentiation of Pancreatic Cancer in 3-Dimensional Culture. Pancreas. PMID 31593010 DOI: 10.1097/Mpa.0000000000001390 |
0.311 |
|
| 2019 |
Garfall AL, Stadtmauer EA, Hwang WT, Lacey SF, Melenhorst JJ, Krevvata M, Carroll MP, Matsui WH, Wang Q, Dhodapkar MV, Dhodapkar K, Das R, Vogl DT, Weiss BM, Cohen AD, et al. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. Jci Insight. 4. PMID 30830874 DOI: 10.1172/jci.insight.127684 |
0.319 |
|
| 2019 |
Begum A, McMillan RH, Chang YT, Penchev VR, Rajeshkumar NV, Maitra A, Goggins MG, Eshelman JR, Wolfgang CL, Rasheed ZA, Matsui W. Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function. Pancreas. PMID 30747824 DOI: 10.1097/Mpa.0000000000001249 |
0.473 |
|
| 2019 |
Penchev VR, Chang YT, Begum A, Ewachiw T, Gocke C, Li J, McMillan RH, Wang Q, Anders R, Marchionni L, Maitra A, Uren A, Rasheed Z, Matsui W. Ezrin promotes stem cell properties in pancreatic ductal adenocarcinoma. Molecular Cancer Research : McR. PMID 30655325 DOI: 10.1158/1541-7786.Mcr-18-0367 |
0.517 |
|
| 2019 |
Park E, Wang Q, Thakar M, Ren Z, Soori M, Gondek L, Matsui W, Gocke C. Protein Synthesis Rates Regulate Tumor-initiating Potential and Chemoresistance in Multiple Myeloma Clinical Lymphoma, Myeloma & Leukemia. 19. DOI: 10.1016/J.Clml.2019.09.213 |
0.316 |
|
| 2018 |
Lau BW, Huh K, Madero-Marroquin R, De Marchi F, Lim Y, Wang Q, Lobo F, Marchionni L, Smith DB, DeZern A, Levis MJ, Aplan PD, Matsui W, Gondek LP. Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity. Oncogene. PMID 30171262 DOI: 10.1038/S41388-018-0431-9 |
0.42 |
|
| 2018 |
Garfall AL, Stadtmauer EA, Hwang WT, Lacey SF, Melenhorst JJ, Krevvata M, Carroll MP, Matsui WH, Wang Q, Dhodapkar MV, Dhodapkar K, Das R, Vogl DT, Weiss BM, Cohen AD, et al. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. Jci Insight. 3. PMID 29669947 DOI: 10.1172/Jci.Insight.120505 |
0.328 |
|
| 2017 |
Ghosh N, Ye X, Tsai HL, Bolaños-Meade J, Fuchs EJ, Luznik L, Swinnen LJ, Gladstone DE, Ambinder RF, Varadhan R, Shanbhag S, Brodsky RA, Borrello IM, Jones RJ, Matsui W, et al. Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Multiple Myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28711728 DOI: 10.1016/J.Bbmt.2017.07.003 |
0.326 |
|
| 2017 |
Begum A, Ewachiw T, Jung C, Huang A, Norberg KJ, Marchionni L, McMillan R, Penchev V, Rajeshkumar NV, Maitra A, Wood L, Wang C, Wolfgang C, DeJesus-Acosta A, Laheru D, ... ... Matsui W, et al. The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma. Plos One. 12: e0180181. PMID 28692661 DOI: 10.1371/Journal.Pone.0180181 |
0.436 |
|
| 2016 |
Alonso S, Hernandez D, Chang YT, Gocke CD, McCray M, Varadhan R, Matsui WH, Jones RJ, Ghiaur G. Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance. The Journal of Clinical Investigation. PMID 27775549 DOI: 10.1172/JCI88152 |
0.364 |
|
| 2016 |
Matsui WH. Cancer stem cell signaling pathways. Medicine. 95: S8-S19. PMID 27611937 DOI: 10.1097/MD.0000000000004765 |
0.412 |
|
| 2016 |
Rich JN, Matsui WH, Chang JC. Cancer stem cells: A nuanced perspective. Medicine. 95: S26-S28. PMID 27611936 DOI: 10.1097/MD.0000000000004559 |
0.356 |
|
| 2016 |
Gocke CB, McMillan R, Wang Q, Begum A, Penchev V, Ali SA, Borrello I, Huff CA, Matsui W. IQGAP1 Scaffold-MAP Kinase Interactions Enhance Multiple Myeloma Clonogenic Growth and Self-Renewal. Molecular Cancer Therapeutics. PMID 27573425 DOI: 10.1158/1535-7163.Mct-16-0323 |
0.403 |
|
| 2016 |
Wang F, Stappenbeck F, Matsui W, Parhami F. Inhibition of Pancreatic Cancer Cell-Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol. Journal of Cellular Biochemistry. PMID 27490478 DOI: 10.1002/Jcb.25668 |
0.398 |
|
| 2016 |
Gondek LP, Zheng G, Ghiaur G, DeZern AE, Matsui W, Yegnasubramanian S, Lin MT, Levis M, Eshleman JR, Varadhan R, Tucker N, Jones R, Gocke CD. Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation. Leukemia. PMID 26975880 DOI: 10.1038/Leu.2016.63 |
0.373 |
|
| 2016 |
Huff CA, Gladstone D, Borrello I, Wang Q, Gocke C, Marshall S, Mahadevia P, Mudenda B, Herbst R, Matsui W. Abstract CT102: Clinical cancer stem cell targeting in multiple myeloma: an early phase trial of the anti-CD19 monoclonal antibody Medi-551 in combination with lenalidomide and dexamethasone Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Ct102 |
0.358 |
|
| 2015 |
Meads MB, Fang B, Mathews L, Gemmer J, Nong L, Rosado-Lopez I, Nguyen T, Ring JE, Matsui W, MacLeod AR, Pachter JA, Hazlehurst LA, Koomen JM, Shain KH. Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma. Oncogene. PMID 26387544 DOI: 10.1038/Onc.2015.334 |
0.475 |
|
| 2015 |
Lombardi LR, Kanakry C, Zahurak M, Durakovic N, Bolaños-Meade J, Kasamon YL, Gladstone DE, Matsui W, Borrello I, Huff CA, Swinnen LJ, Brodsky RA, Ambinder RF, Fuchs EJ, Rosner GL, et al. Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre- and post-transplantation cyclophosphamide. Leukemia & Lymphoma. 1-30. PMID 26292764 DOI: 10.3109/10428194.2015.1071488 |
0.306 |
|
| 2015 |
Lim Y, Gondek L, Li L, Wang Q, Ma H, Chang E, Huso DL, Foerster S, Marchionni L, McGovern K, Watkins DN, Peacock CD, Levis M, Smith BD, Merchant AA, ... ... Matsui W, et al. Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia. Science Translational Medicine. 7: 291ra96. PMID 26062848 DOI: 10.1126/Scitranslmed.Aaa5731 |
0.386 |
|
| 2015 |
Noonan KA, Huff CA, Davis J, Lemas MV, Fiorino S, Bitzan J, Ferguson A, Emerling A, Luznik L, Matsui W, Powell J, Fuchs E, Rosner GL, Epstein C, Rudraraju L, et al. Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma. Science Translational Medicine. 7: 288ra78. PMID 25995224 DOI: 10.1126/Scitranslmed.Aaa7014 |
0.424 |
|
| 2015 |
Alonso S, Matsui W, Jones RJ, Ghiaur G. Bone Marrow Niche - Multiple Myeloma Cross-Talk Generates Bortezomib Resistance Blood. 126: 914-914. DOI: 10.1182/Blood.V126.23.914.914 |
0.446 |
|
| 2015 |
Begum A, Ewachiw T, McMillan R, Penchev V, Jung C, Huang A, Norberg J, Rajeshkumar N, Maitra A, Matsui W, Rasheed ZA. Abstract A70: The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A70 |
0.497 |
|
| 2014 |
Kanakry CG, Tsai HL, Bolaños-Meade J, Smith BD, Gojo I, Kanakry JA, Kasamon YL, Gladstone DE, Matsui W, Borrello I, Huff CA, Swinnen LJ, Powell JD, Pratz KW, DeZern AE, et al. Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS. Blood. 124: 3817-27. PMID 25316679 DOI: 10.1182/Blood-2014-07-587477 |
0.342 |
|
| 2014 |
Agarwal JR, Wang Q, Tanno T, Rasheed Z, Merchant A, Ghosh N, Borrello I, Huff CA, Parhami F, Matsui W. Activation of liver X receptors inhibits hedgehog signaling, clonogenic growth, and self-renewal in multiple myeloma. Molecular Cancer Therapeutics. 13: 1873-81. PMID 24807964 DOI: 10.1158/1535-7163.Mct-13-0997 |
0.446 |
|
| 2014 |
Kim JH, Thimmulappa RK, Kumar V, Cui W, Kumar S, Kombairaju P, Zhang H, Margolick J, Matsui W, Macvittie T, Malhotra SV, Biswal S. NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation. The Journal of Clinical Investigation. 124: 730-41. PMID 24463449 DOI: 10.1172/Jci70812 |
0.376 |
|
| 2014 |
Tanno T, Lim Y, Wang Q, Chesi M, Bergsagel PL, Matthews G, Johnstone RW, Ghosh N, Borrello I, Huff CA, Matsui W. Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells. Blood. 123: 725-33. PMID 24345755 DOI: 10.1182/Blood-2013-08-524025 |
0.5 |
|
| 2014 |
Bailey JM, Alsina J, Rasheed ZA, McAllister FM, Fu YY, Plentz R, Zhang H, Pasricha PJ, Bardeesy N, Matsui W, Maitra A, Leach SD. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. Gastroenterology. 146: 245-56. PMID 24096005 DOI: 10.1053/J.Gastro.2013.09.050 |
0.493 |
|
| 2014 |
Bot A, Chiriva-Internati M, Cornforth A, Czerniecki BJ, Ferrone S, Geles K, Greenberg PD, Hurt E, Koya RC, Manjili MH, Matsui W, Morgan RA, Palena CM, Powell Jr DJ, Restifo NP, et al. Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-6 |
0.425 |
|
| 2014 |
Gondek LP, Lim Y, Makishima H, Wang Q, Maciejewski JP, Aplan PD, DeZern AE, Matsui W. Aberrant Hedgehog Pathway Activity Marks Clinical MDS Progression and Accelerates Leukemic Transformation in Vivo Blood. 124: 528-528. DOI: 10.1182/Blood.V124.21.528.528 |
0.462 |
|
| 2014 |
Gocke CB, Wang Q, McMillan R, Penchev V, Sage J, Khavari PA, Matsui W. Inhibiting Oncogenic RAS in Multiple Myeloma By Targeting Scaffold-ERK Interactions Blood. 124: 2089-2089. DOI: 10.1182/Blood.V124.21.2089.2089 |
0.38 |
|
| 2014 |
Shain KH, Meads MB, Fang B, Mathews L, Gemmer J, Nong L, Rosado-Lopez I, Ring JE, MacLeod R, Hazlehurst L, Lynch C, Pachter JA, Matsui W, Koomen J, Nguyen T. Targeting PYK2 Mediates Microenvironment-Specific Myeloma Cell Death Blood. 124: 2081-2081. DOI: 10.1182/Blood.V124.21.2081.2081 |
0.49 |
|
| 2013 |
Anchoori RK, Karanam B, Peng S, Wang JW, Jiang R, Tanno T, Orlowski RZ, Matsui W, Zhao M, Rudek MA, Hung CF, Chen X, Walters KJ, Roden RB. A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer. Cancer Cell. 24: 791-805. PMID 24332045 DOI: 10.1016/J.Ccr.2013.11.001 |
0.306 |
|
| 2013 |
Alamgeer M, Peacock CD, Matsui W, Ganju V, Watkins DN. Cancer stem cells in lung cancer: Evidence and controversies. Respirology (Carlton, Vic.). 18: 757-64. PMID 23586700 DOI: 10.1111/Resp.12094 |
0.484 |
|
| 2013 |
Wang GM, Wong HY, Konishi H, Blair BG, Abukhdeir AM, Gustin JP, Rosen DM, Denmeade SR, Rasheed Z, Matsui W, Garay JP, Mohseni M, Higgins MJ, Cidado J, Jelovac D, et al. Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation. Cancer Research. 73: 3248-61. PMID 23580570 DOI: 10.1158/0008-5472.Can-12-1578 |
0.388 |
|
| 2013 |
Carvalho FL, Simons BW, Antonarakis ES, Rasheed Z, Douglas N, Villegas D, Matsui W, Berman DM. Tumorigenic potential of circulating prostate tumor cells. Oncotarget. 4: 413-21. PMID 23530114 DOI: 10.18632/Oncotarget.895 |
0.406 |
|
| 2013 |
Ghosh N, Ye X, Bolaños-Meade J, Fuchs EJ, Luznik L, Kanakry JA, Brodsky RA, Levis M, Swinnen LJ, Gladstone D, Kasamon YL, Ambinder RF, Jones RJ, Matsui W, Borrello IM, et al. Outcomes Of Allogeneic Blood Or Marrow Transplantation (AlloBMT) In Multiple Myeloma With Post-Transplantation Cyclophosphamide (PTCy) Blood. 122: 3407-3407. DOI: 10.1182/Blood.V122.21.3407.3407 |
0.324 |
|
| 2013 |
Noonan K, Rudraraju L, Ferguson A, Sidorski A, Casildo A, Griffin E, Lee S, Ghosh N, Matsui W, Huff C, Borrello IM. Dissecting The Potential Role Of Prevnar As An Anti-Myeloma Vaccine Blood. 122: 1980-1980. DOI: 10.1182/Blood.V122.21.1980.1980 |
0.36 |
|
| 2013 |
Bailey JM, Alsina J, Rasheed Z, Fu Y, McAllister F, Pasricha P, Matsui W, Maitra A, Leach S. Abstract 5008: A morphologically distinct cancer initiating cell in human and murine PanIN and pancreatic cancer. Cancer Research. 73: 5008-5008. DOI: 10.1158/1538-7445.Am2013-5008 |
0.383 |
|
| 2013 |
Kumar R, Dholakia A, Herman J, Maitra A, Hong S, Matsui W, Wolfgang C, Laheru D, Iacobuzio-Donohue C, Rasheed Z. ALDH-Expressing Cancer Stem Cells Are Associated With Inferior Survival in Patients With Resected Pancreatic Adenocarcinoma Treated With Adjuvant Chemoradiation International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.479 |
0.427 |
|
| 2012 |
Penchev VR, Rasheed ZA, Maitra A, Matsui W. Heterogeneity and targeting of pancreatic cancer stem cells Clinical Cancer Research. 18: 4277-4284. PMID 22896694 DOI: 10.1158/1078-0432.Ccr-11-3112 |
0.493 |
|
| 2012 |
Mizuma M, Rasheed ZA, Yabuuchi S, Omura N, Campbell NR, de Wilde RF, De Oliveira E, Zhang Q, Puig O, Matsui W, Hidalgo M, Maitra A, Rajeshkumar NV. The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models. Molecular Cancer Therapeutics. 11: 1999-2009. PMID 22752426 DOI: 10.1158/1535-7163.Mct-12-0017 |
0.492 |
|
| 2012 |
McMillan R, Matsui W. Molecular pathways: the hedgehog signaling pathway in cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4883-8. PMID 22718857 DOI: 10.1158/1078-0432.Ccr-11-2509 |
0.402 |
|
| 2012 |
Tai YT, Chang BY, Kong SY, Fulciniti M, Yang G, Calle Y, Hu Y, Lin J, Zhao JJ, Cagnetta A, Cea M, Sellitto MA, Zhong MY, Wang Q, Acharya C, ... ... Matsui W, et al. Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma. Blood. 120: 1877-87. PMID 22689860 DOI: 10.1182/Blood-2011-12-396853 |
0.456 |
|
| 2012 |
Lin TL, Matsui W. Hedgehog pathway as a drug target: Smoothened inhibitors in development. Oncotargets and Therapy. 5: 47-58. PMID 22500124 DOI: 10.2147/Ott.S21957 |
0.441 |
|
| 2012 |
Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, Harris J, Yen RW, Ahuja N, Brock MV, Stearns V, ... ... Matsui W, et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell. 21: 430-46. PMID 22439938 DOI: 10.1016/J.Ccr.2011.12.029 |
0.4 |
|
| 2012 |
Easwaran H, Johnstone SE, Van Neste L, Ohm J, Mosbruger T, Wang Q, Aryee MJ, Joyce P, Ahuja N, Weisenberger D, Collisson E, Zhu J, Yegnasubramanian S, Matsui W, Baylin SB. A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Research. 22: 837-49. PMID 22391556 DOI: 10.1101/Gr.131169.111 |
0.414 |
|
| 2012 |
Rasheed ZA, Matsui W. Biological and clinical relevance of stem cells in pancreatic adenocarcinoma. Journal of Gastroenterology and Hepatology. 27: 15-8. PMID 22320910 DOI: 10.1111/J.1440-1746.2011.07015.X |
0.475 |
|
| 2012 |
Ghiaur G, Gerber JM, Matsui W, Jones RJ. Cancer stem cells: relevance to clinical transplantation. Current Opinion in Oncology. 24: 170-5. PMID 22314617 DOI: 10.1097/Cco.0B013E32834Ec015 |
0.514 |
|
| 2012 |
Van Valckenborgh E, Matsui W, Agarwal P, Lub S, Dehui X, De Bruyne E, Menu E, Empsen C, van Grunsven L, Agarwal J, Wang Q, Jernberg-Wiklund H, Vanderkerken K. Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model. Leukemia. 26: 1436-9. PMID 22289925 DOI: 10.1038/Leu.2011.373 |
0.362 |
|
| 2012 |
Matsui W, Borrello I, Mitsiades C. Autologous stem cell transplantation and multiple myeloma cancer stem cells. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: S27-32. PMID 22226109 DOI: 10.1016/J.Bbmt.2011.10.036 |
0.523 |
|
| 2012 |
Huff CA, Wang Q, Badros AZ, Jones RJ, Reddy A, Nishimoto K, Stuart MJ, Kelsey SM, Matsui W. The Telomerase Inhibitor, Imetelstat, Rapidly Reduces Myeloma Cancer Stem Cells (CSCs) in a Phase II Trial Blood. 120: 4898-4898. DOI: 10.1182/Blood.V120.21.4898.4898 |
0.425 |
|
| 2012 |
Rasheed ZA, Jung C, Huang A, Norberg J, Rajeshkumar NV, Maitra A, Matsui W. Abstract A70: The extracellular matrix regulates pancreatic cancer stem cell function via focal adhesion kinase signaling. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A70 |
0.505 |
|
| 2012 |
Tsai H, Li H, Neste LV, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, Harris J, Yen RC, Ahuja N, Brock MV, Stearns V, ... ... Matsui W, et al. Abstract 995: Transient low doses of DNA demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells Cancer Research. 72: 995-995. DOI: 10.1158/1538-7445.Am2012-995 |
0.457 |
|
| 2012 |
Bailey JM, Rasheed ZA, McAllister F, Alsina J, Auricchio GM, Maitra A, Hollingsworth MA, Matsui W, Leach SD. Abstract 5338: Pancreatic cancer tumor initiating cells are marked by the presence of cell surface associated acetylated alpha tubulin Cancer Research. 72: 5338-5338. DOI: 10.1158/1538-7445.Am2012-5338 |
0.485 |
|
| 2012 |
Rasheed ZA, Rajeshkumar N, Jung C, Huang A, Agarwal J, Oliviero E, Rudek M, Zhao M, He P, DeJesus-Acosta A, Laheru D, Maitra A, Parhami F, Matsui W. Abstract 3494: Liver X receptor activation represents a novel strategy to block Hedgehog signaling in pancreatic adenocarcinoma and enhance the antitumor effect of gemcitabine Cancer Research. 72: 3494-3494. DOI: 10.1158/1538-7445.Am2012-3494 |
0.471 |
|
| 2012 |
Tai Y, Chang B, Kong S, Fulciniti M, Yang G, Calle Y, Hu Y, Lin J, Zhao J, Cagnetta A, Cea M, Sellitto M, Chen M, Carrasco DR, Elias L, ... ... Matsui W, et al. Abstract 2934: Targeting Bruton's tyrosine kinase with PCI-32765 blocks growth and survival of multiple myeloma and Waldenström macroglobulinemia via potent inhibition of osteoclastogenesis, cytokines/chemokine secretion, and myeloma stem-like cells in the bone marrow microenvironment Cancer Research. 72: 2934-2934. DOI: 10.1158/1538-7445.Am2012-2934 |
0.49 |
|
| 2011 |
Matsui W. Perspective: A model disease. Nature. 480: S58. PMID 22169808 DOI: 10.1038/480S58A |
0.309 |
|
| 2011 |
Merchant AA, Singh A, Matsui W, Biswal S. The redox-sensitive transcription factor Nrf2 regulates murine hematopoietic stem cell survival independently of ROS levels. Blood. 118: 6572-9. PMID 22039262 DOI: 10.1182/Blood-2011-05-355362 |
0.42 |
|
| 2011 |
Feldmann G, Mishra A, Bisht S, Karikari C, Garrido-Laguna I, Rasheed Z, Ottenhof NA, Dadon T, Alvarez H, Fendrich V, Rajeshkumar NV, Matsui W, Brossart P, Hidalgo M, Bannerji R, et al. Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models. Cancer Biology & Therapy. 12: 598-609. PMID 21768779 DOI: 10.4161/Cbt.12.7.16475 |
0.424 |
|
| 2011 |
Gladstone DE, Bolaños-Meade J, Huff CA, Zahurak M, Flinn I, Borrello I, Luznik L, Fuchs E, Kasamon Y, Matsui W, Powell J, Levitsky H, Brodsky RA, Ambinder R, Jones RJ, et al. High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas. Leukemia & Lymphoma. 52: 2076-81. PMID 21756035 DOI: 10.3109/10428194.2011.594191 |
0.449 |
|
| 2011 |
Tanno T, Matsui W. Development and maintenance of cancer stem cells under chronic inflammation. Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi. 78: 138-45. PMID 21720087 DOI: 10.1272/Jnms.78.138 |
0.494 |
|
| 2011 |
Rasheed ZA, Kowalski J, Smith BD, Matsui W. Concise review: Emerging concepts in clinical targeting of cancer stem cells Stem Cells. 29: 883-887. PMID 21509907 DOI: 10.1002/Stem.648 |
0.431 |
|
| 2011 |
Gerber JM, Qin L, Kowalski J, Smith BD, Griffin CA, Vala MS, Collector MI, Perkins B, Zahurak M, Matsui W, Gocke CD, Sharkis SJ, Levitsky HI, Jones RJ. Characterization of chronic myeloid leukemia stem cells. American Journal of Hematology. 86: 31-7. PMID 21132730 DOI: 10.1002/Ajh.21915 |
0.451 |
|
| 2011 |
Noonan K, Huff CA, Sproul JMD, Lemas MVM, Rudraraju L, Luznik L, Powell J, Bolaños-Meade J, Bitzan J, Fiorino S, Matsui W, Jones RJ, Borrello IM. Phase I/II Study of Marrow Infiltrating Lymphocytes (MILs) Generates Measurable Myeloma-Specific Immunity in the Autologous Stem Cell Transplant (SCT) Setting Blood. 118: 997-997. DOI: 10.1182/Blood.V118.21.997.997 |
0.4 |
|
| 2011 |
Tai Y, Chang BY, Kong S, Fulciniti M, Yang G, Calle Y, Hu Y, Lin J, Zhao J, Cea M, Cagnetta A, Sellitto MA, Chen M, Hunter Z, Carrasco R, ... ... Matsui W, et al. Targeting Brouton's Tyrosine Kinase with PCI-32765 Blocks Growth and Survival of Multiple Myeloma and Waldenstrom Macroglobulinemia Via Potent Inhibition of Osteoclastogenesis, Cytokines/Chemokine Secretion, and Myeloma Stem-Like Cells in the Bone Marrow Microenvironment Blood. 118: 883-883. DOI: 10.1182/Blood.V118.21.883.883 |
0.479 |
|
| 2011 |
Tanno T, Merchant A, Agarwal JR, Wang Q, Matsui W. The TGF- β Family Member Growth Differentiation Factor 15 (GDF15) Regulates the Self-Renewal of Multiple Myeloma Cancer Stem Cells Blood. 118: 2954-2954. DOI: 10.1182/Blood.V118.21.2954.2954 |
0.481 |
|
| 2011 |
Easwaran H, Johnstone SE, Neste LV, Ohm JE, Mosbruger T, Aryee M, Yegnasubramanian S, Matsui W, Baylin SB. Abstract LB-174: A DNA hypermethylation module for the stem/progenitor cell signature of cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-174 |
0.424 |
|
| 2011 |
Bailey JM, Rasheed Z, Matsui W, Maitra A, Hollingsworth MA, Leach SD. Abstract 2449: Pancreatic cancer tumor initiating cells are marked by the presence of a primary cilium Cancer Research. 71: 2449-2449. DOI: 10.1158/1538-7445.Am2011-2449 |
0.493 |
|
| 2011 |
Rasheed ZA, Huang A, Norberg J, Wang Q, Penchev V, Rajeshkumar N, Maitra A, Matsui W. Abstract 2446: Targeting pancreatic cancer stem cells via the tumor microenvironment Cancer Research. 71: 2446-2446. DOI: 10.1158/1538-7445.Am2011-2446 |
0.503 |
|
| 2010 |
Lin TL, Wang QH, Brown P, Peacock C, Merchant AA, Brennan S, Jones E, McGovern K, Watkins DN, Sakamoto KM, Matsui W. Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926. Plos One. 5: e15262. PMID 21203400 DOI: 10.1371/Journal.Pone.0015262 |
0.414 |
|
| 2010 |
Rasheed Z, Wang Q, Matsui W. Isolation of stem cells from human pancreatic cancer xenografts Journal of Visualized Experiments : Jove. PMID 20972397 DOI: 10.3791/2169 |
0.426 |
|
| 2010 |
Ohm JE, Mali P, Van Neste L, Berman DM, Liang L, Pandiyan K, Briggs KJ, Zhang W, Argani P, Simons B, Yu W, Matsui W, Van Criekinge W, Rassool FV, Zambidis E, et al. Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. Cancer Research. 70: 7662-73. PMID 20841480 DOI: 10.1158/0008-5472.Can-10-1361 |
0.462 |
|
| 2010 |
Brennan SK, Wang Q, Tressler R, Harley C, Go N, Bassett E, Huff CA, Jones RJ, Matsui W. Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms. Plos One. 5. PMID 20824134 DOI: 10.1371/Journal.Pone.0012487 |
0.528 |
|
| 2010 |
Ishizawa K, Rasheed ZA, Karisch R, Wang Q, Kowalski J, Susky E, Pereira K, Karamboulas C, Moghal N, Rajeshkumar NV, Hidalgo M, Tsao M, Ailles L, Waddell TK, Maitra A, ... ... Matsui W, et al. Tumor-initiating cells are rare in many human tumors. Cell Stem Cell. 7: 279-82. PMID 20804964 DOI: 10.1016/J.Stem.2010.08.009 |
0.421 |
|
| 2010 |
Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. The American Journal of Pathology. 177: 1491-502. PMID 20671264 DOI: 10.2353/Ajpath.2010.091021 |
0.44 |
|
| 2010 |
Rajeshkumar NV, Rasheed ZA, García-García E, López-Ríos F, Fujiwara K, Matsui WH, Hidalgo M. A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model Molecular Cancer Therapeutics. 9: 2582-2592. PMID 20660600 DOI: 10.1158/1535-7163.MCT-10-0370 |
0.393 |
|
| 2010 |
Brennan SK, Meade B, Wang Q, Merchant AA, Kowalski J, Matsui W. Mantle cell lymphoma activation enhances bortezomib sensitivity. Blood. 116: 4185-91. PMID 20570863 DOI: 10.1182/Blood-2010-02-268375 |
0.499 |
|
| 2010 |
Merchant AA, Matsui W. Targeting Hedgehog--a cancer stem cell pathway. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3130-40. PMID 20530699 DOI: 10.1158/1078-0432.Ccr-09-2846 |
0.449 |
|
| 2010 |
Agarwal JR, Matsui W. Multiple myeloma: a paradigm for translation of the cancer stem cell hypothesis. Anti-Cancer Agents in Medicinal Chemistry. 10: 116-20. PMID 20184542 DOI: 10.2174/187152010790909344 |
0.546 |
|
| 2010 |
Rasheed ZA, Yang J, Wang Q, Kowalski J, Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, Goggins M, Iacobuzio-Donahue C, Berman DM, Laheru D, Jimeno A, ... ... Matsui W, et al. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma Journal of the National Cancer Institute. 102: 340-351. PMID 20164446 DOI: 10.1093/Jnci/Djp535 |
0.494 |
|
| 2010 |
Luznik L, Bolaños-Meade J, Zahurak M, Chen AR, Smith BD, Brodsky R, Huff CA, Borrello I, Matsui W, Powell JD, Kasamon Y, Goodman SN, Hess A, Levitsky HI, Ambinder RF, et al. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood. 115: 3224-30. PMID 20124511 DOI: 10.1182/Blood-2009-11-251595 |
0.343 |
|
| 2010 |
Merchant A, Joseph G, Wang Q, Brennan S, Matsui W. Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood. 115: 2391-6. PMID 20107231 DOI: 10.1182/Blood-2009-09-241703 |
0.445 |
|
| 2010 |
Kasamon YL, Jones RJ, Brodsky RA, Fuchs EJ, Matsui W, Luznik L, Powell JD, Blackford AL, Goodrich A, Gocke CD, Abrams RA, Ambinder RF, Flinn IW. Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 21: 1203-10. PMID 19880437 DOI: 10.1093/Annonc/Mdp484 |
0.377 |
|
| 2010 |
Matsui W. Origin of the Myeloma Stem Cell Blood. 116. DOI: 10.1182/Blood.V116.21.Sci-4.Sci-4 |
0.544 |
|
| 2010 |
Eunpi C, Matsui W, Kowalski J, Tsai H, Jones RJ, Smith BD. Combination Therapy with Entinostat (MS-275) and GM-CSF to Enhance Differentiation In Myeloid Malignancies Blood. 116: 3312-3312. DOI: 10.1182/Blood.V116.21.3312.3312 |
0.388 |
|
| 2010 |
Lim Y, Hedayati M, Merchant A, Zhang Y, DeWeese T, Matsui W. Improved Survival and Recovery of Hematopoiesis Following Lethal Radiation by Chloroquine-Mediated Activation of ATM Blood. 116: 2228-2228. DOI: 10.1182/Blood.V116.21.2228.2228 |
0.333 |
|
| 2010 |
Tsai H, Neste LV, Li H, Cai Y, Robert C, Shin JJ, Pappou E, Yen R, Minn I, Ahuja N, Brock MV, Rassool FV, Jang Y, Sharkis SJ, Matsui W, et al. Abstract LB-88: Transient exposure to low-dose decitabine and azacytidine reprograms cancer cells to produce a prolonged antitumor response Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-88 |
0.43 |
|
| 2010 |
Joseph I, Matsui W, LaPorta CAM, Tabori U, Kornblum H, Herbert B, Harley C, Tressler RJ. Abstract 4291: Imetelstat, a telomerase inhibitor in phase I trials in solid tumor and hematological malignancies, has broad activity against multiple types of cancer stem cells Cancer Research. 70: 4291-4291. DOI: 10.1158/1538-7445.Am10-4291 |
0.485 |
|
| 2010 |
Matsui W. Abstract PL3-2: Translating multiple myeloma stem cells Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcme10-Pl3-2 |
0.553 |
|
| 2009 |
Brandt WD, Matsui W, Rosenberg JE, He X, Ling S, Schaeffer EM, Berman DM. Urothelial carcinoma: stem cells on the edge. Cancer Metastasis Reviews. 28: 291-304. PMID 20012172 DOI: 10.1007/S10555-009-9187-6 |
0.506 |
|
| 2009 |
Brennan SK, Matsui W. Cancer stem cells: controversies in multiple myeloma. Journal of Molecular Medicine (Berlin, Germany). 87: 1079-85. PMID 19760278 DOI: 10.1007/S00109-009-0531-7 |
0.521 |
|
| 2009 |
He X, Marchionni L, Hansel DE, Yu W, Sood A, Yang J, Parmigiani G, Matsui W, Berman DM. Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells (Dayton, Ohio). 27: 1487-95. PMID 19544456 DOI: 10.1002/Stem.92 |
0.508 |
|
| 2009 |
Sun P, Xia S, Lal B, Eberhart CG, Quinones-Hinojosa A, Maciaczyk J, Matsui W, Dimeco F, Piccirillo SM, Vescovi AL, Laterra J. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells (Dayton, Ohio). 27: 1473-86. PMID 19544453 DOI: 10.1002/Stem.89 |
0.495 |
|
| 2009 |
Merchant AA, Matsui W. Smoothening the controversial role of hedgehog in hematopoiesis. Cell Stem Cell. 4: 470-1. PMID 19497273 DOI: 10.1016/J.Stem.2009.05.006 |
0.388 |
|
| 2009 |
Mullendore ME, Koorstra JB, Li YM, Offerhaus GJ, Fan X, Henderson CM, Matsui W, Eberhart CG, Maitra A, Feldmann G. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2291-301. PMID 19258443 DOI: 10.1158/1078-0432.Ccr-08-2004 |
0.447 |
|
| 2009 |
Lin T, Jones RJ, Matsui W. Cancer stem cells: relevance to SCT. Bone Marrow Transplantation. 43: 517-23. PMID 19234507 DOI: 10.1038/Bmt.2009.19 |
0.535 |
|
| 2009 |
Beauchamp E, Bulut G, Abaan O, Chen K, Merchant A, Matsui W, Endo Y, Rubin JS, Toretsky J, Uren A. GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein. The Journal of Biological Chemistry. 284: 9074-82. PMID 19189974 DOI: 10.1074/Jbc.M806233200 |
0.403 |
|
| 2009 |
Jones RJ, Gocke CD, Kasamon YL, Miller CB, Perkins B, Barber JP, Vala MS, Gerber JM, Gellert LL, Siedner M, Lemas MV, Brennan S, Ambinder RF, Matsui W. Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood. 113: 5920-6. PMID 19188663 DOI: 10.1182/Blood-2008-11-189688 |
0.423 |
|
| 2009 |
Jiang T, Collins BJ, Jin N, Watkins DN, Brock MV, Matsui W, Nelkin BD, Ball DW. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Research. 69: 845-54. PMID 19176379 DOI: 10.1158/0008-5472.Can-08-2762 |
0.444 |
|
| 2009 |
Jimeno A, Feldmann G, Suárez-Gauthier A, Rasheed Z, Solomon A, Zou GM, Rubio-Viqueira B, García-García E, López-Ríos F, Matsui W, Maitra A, Hidalgo M. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Molecular Cancer Therapeutics. 8: 310-4. PMID 19174553 DOI: 10.1158/1535-7163.Mct-08-0924 |
0.497 |
|
| 2009 |
Ghosh N, Matsui W. Cancer stem cells in multiple myeloma. Cancer Letters. 277: 1-7. PMID 18809245 DOI: 10.1016/J.Canlet.2008.08.005 |
0.503 |
|
| 2009 |
Merchant A, Singh A, Joseph G, Wang Q, Zhang P, Brennan S, Biswal S, Matsui W. Nrf2, a Critical Regulator of Oxidative Stress, Is Required for HSC Function and Cytokine Response. Blood. 114: 1492-1492. DOI: 10.1182/Blood.V114.22.1492.1492 |
0.38 |
|
| 2009 |
Jones RJ, Gocke CD, Ambinder RF, Matsui W. Hodgkin lymphoma stem cells Blood. 114: 3971-3972. DOI: 10.1182/Blood-2009-08-237545 |
0.415 |
|
| 2009 |
Gendreau SB, Hawkins D, Ho C, Lewin A, Lin T, Merchant A, Rowley RB, Wang Q, Matsui W, Fargnoli J. Abstract B192: Preclinical characterization of BMS‐833923 (XL139), a hedgehog (HH) pathway inhibitor in early clinical development Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-B192 |
0.48 |
|
| 2008 |
Feldmann G, Fendrich V, McGovern K, Bedja D, Bisht S, Alvarez H, Koorstra JB, Habbe N, Karikari C, Mullendore M, Gabrielson KL, Sharma R, Matsui W, Maitra A. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Molecular Cancer Therapeutics. 7: 2725-35. PMID 18790753 DOI: 10.1158/1535-7163.Mct-08-0573 |
0.477 |
|
| 2008 |
Huff CA, Matsui W. Multiple myeloma cancer stem cells. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2895-900. PMID 18539970 DOI: 10.1200/Jco.2007.15.8428 |
0.467 |
|
| 2008 |
Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF, Huff CA, Matsui W, Bolaños-Meade J, Borrello I, Powell JD, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 641-50. PMID 18489989 DOI: 10.1016/J.Bbmt.2008.03.005 |
0.314 |
|
| 2008 |
Warlick ED, O'Donnell PV, Borowitz M, Grupka N, Decloe L, Garrett-Mayer E, Borrello I, Brodsky R, Fuchs E, Huff CA, Luznik L, Matsui W, Ambinder R, Jones RJ, Smith BD. Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes. Leukemia Research. 32: 1439-47. PMID 18261793 DOI: 10.1016/J.Leukres.2007.12.017 |
0.354 |
|
| 2008 |
Matsui W, Wang Q, Barber JP, Brennan S, Smith BD, Borrello I, McNiece I, Lin L, Ambinder RF, Peacock C, Watkins DN, Huff CA, Jones RJ. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Research. 68: 190-7. PMID 18172311 DOI: 10.1158/0008-5472.Can-07-3096 |
0.49 |
|
| 2008 |
Lauring J, Abukhdeir AM, Konishi H, Garay JP, Gustin JP, Wang Q, Arceci RJ, Matsui W, Park BH. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood. 111: 856-64. PMID 17942756 DOI: 10.1182/Blood-2007-05-088674 |
0.383 |
|
| 2008 |
Brennan S, Meade B, Wang Q, Weiner G, Matsui W. Cancer Stem Cell Activity in Mantle Cell Lymphoma Is Inhibited by TLR9 Activation Blood. 112: 884-884. DOI: 10.1182/Blood.V112.11.884.884 |
0.517 |
|
| 2008 |
Savage WJ, Barber J, Cheng L, Chen G, Thoburn C, Hu R, Mukhina G, Matsui W, Hess A, Jones R, Brodsky RA. GPI-Anchored Protein Deficiency Confers Resistance to Apoptosis in PNH. Blood. 112: 2035-2035. DOI: 10.1182/Blood.V112.11.2035.2035 |
0.396 |
|
| 2008 |
Merchant A, Joseph G, Matsui W. Hedgehog Signaling Regulates HSC Proliferation. Blood. 112: 1390-1390. DOI: 10.1182/Blood.V112.11.1390.1390 |
0.41 |
|
| 2008 |
Chumsri S, Matsui W, Burger AM. Therapeutic Implications of Leukemic Stem Cell Pathways Aacr Education Book. 2008: 397-406. DOI: 10.1158/Aacr.Edb-Ccr-07-1088 |
0.465 |
|
| 2007 |
Jones RJ, Matsui W. Cancer Stem Cells: From Bench to Bedside. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 47-52. PMID 18167509 DOI: 10.1016/J.Bbmt.2006.10.010 |
0.487 |
|
| 2007 |
Chumsri S, Matsui W, Burger AM. Therapeutic implications of leukemic stem cell pathways. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 6549-54. PMID 18006753 DOI: 10.1158/1078-0432.Ccr-07-1088 |
0.5 |
|
| 2007 |
Bolaños-Meade J, Garrett-Mayer E, Luznik L, Anders V, Webb J, Fuchs EJ, Huff CA, Matsui W, Borrello IM, Brodsky R, Kasamon YL, Swinnen LJ, Flinn IW, Ambinder RF, Jones RJ, et al. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1185-91. PMID 17889355 DOI: 10.1016/J.Bbmt.2007.06.011 |
0.335 |
|
| 2007 |
Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W, Piccirillo S, Vescovi AL, DiMeco F, Olivi A, Eberhart CG. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells (Dayton, Ohio). 25: 2524-33. PMID 17628016 DOI: 10.1634/Stemcells.2007-0166 |
0.532 |
|
| 2007 |
Lin TL, Vala MS, Barber JP, Karp JE, Smith BD, Matsui W, Jones RJ. Induction of acute lymphocytic leukemia differentiation by maintenance therapy. Leukemia. 21: 1915-20. PMID 17611566 DOI: 10.1038/Sj.Leu.2404823 |
0.416 |
|
| 2007 |
Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, Kim J, Devereux WL, Rhodes JT, Huff CA, Beachy PA, Watkins DN, Matsui W. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proceedings of the National Academy of Sciences of the United States of America. 104: 4048-53. PMID 17360475 DOI: 10.1073/Pnas.0611682104 |
0.539 |
|
| 2007 |
Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M, Karikari C, Alvarez H, Iacobuzio-Donahue C, Jimeno A, Gabrielson KL, Matsui W, Maitra A. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Research. 67: 2187-96. PMID 17332349 DOI: 10.1158/0008-5472.Can-06-3281 |
0.391 |
|
| 2007 |
Wang Q, Peacock C, Hensley K, Brennan S, Merchant A, Jones E, Freed I, Ambinder R, McGovern K, Tremblay M, Watkins DN, Matsui W. Aberrant Hedgehog Signaling Represents a Novel Therapeutic Target in B Cell Lymphomas. Blood. 110: 3582-3582. DOI: 10.1182/Blood.V110.11.3582.3582 |
0.543 |
|
| 2007 |
Lauring J, Abukhdeir AM, Konishi H, Garay JP, Gustin JP, Wang Q, Arceci RJ, Matsui W, Park BH. The MMSET Gene Contributes to the Growth, Adhesion, and Tumorigencitiy of t(4;14) Multiple Myeloma Cells. Blood. 110: 2636-2636. DOI: 10.1182/Blood.V110.11.2636.2636 |
0.381 |
|
| 2006 |
Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, Eberhart CG. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Research. 66: 7445-52. PMID 16885340 DOI: 10.1158/0008-5472.Can-06-0858 |
0.516 |
|
| 2006 |
Huff CA, Matsui WH, Smith BD, Jones RJ. Strategies to eliminate cancer stem cells: clinical implications. European Journal of Cancer (Oxford, England : 1990). 42: 1293-7. PMID 16644203 DOI: 10.1016/j.ejca.2006.01.045 |
0.368 |
|
| 2006 |
Huff CA, Matsui W, Smith BD, Jones RJ. The paradox of response and survival in cancer therapeutics. Blood. 107: 431-4. PMID 16150939 DOI: 10.1182/Blood-2005-06-2517 |
0.504 |
|
| 2006 |
Jones RJ, Lin L, Gocke C, Hensley K, Siedner M, Barber JP, Kasamon Y, Ambinder RF, Matsui W. Clonotypic B Cells Circulate in Hodgkin’s Lymphoma (HL). Blood. 108: 470-470. DOI: 10.1182/Blood.V108.11.470.470 |
0.437 |
|
| 2006 |
Matsui W, Wang Q, Vala M, Barber JP, Meeker A, Tressler R, Harley C, Huff CA, Smith BD, Jones RJ. Cancer Stem Cell Targeting in Multiple Myeloma by GRN163L, a Novel and Potent Telomerase Inhibitor. Blood. 108: 2540-2540. DOI: 10.1182/Blood.V108.11.2540.2540 |
0.529 |
|
| 2006 |
Matsui W, Brodsky RA, Smith BD, Borowitz MJ, Jones RJ. Reply to |[lsquo]|Quantification of marrow CD34|[plus]| cells: an important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia|[rsquo]| by A Orazi Leukemia. 20: 2041-2042. DOI: 10.1038/Sj.Leu.2404394 |
0.33 |
|
| 2005 |
Angstreich GR, Matsui W, Huff CA, Vala MS, Barber J, Hawkins AL, Griffin CA, Smith BD, Jones RJ. Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors. British Journal of Haematology. 130: 373-81. PMID 16042686 DOI: 10.1111/J.1365-2141.2005.05606.X |
0.391 |
|
| 2005 |
Vonderheid EC, Matsui W. Do neoplastic stem cells underlie the pathogenesis of cutaneous lymphomas? Archives of Dermatology. 141: 641-2; author reply . PMID 15897396 DOI: 10.1001/Archderm.141.5.641 |
0.439 |
|
| 2005 |
Matsui W, Smith BD, Vala M, Beal N, Huff CA, Diehl LF, Jones RJ. Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia British Journal of Haematology. 128: 853-862. PMID 15755292 DOI: 10.1111/J.1365-2141.2005.05395.X |
0.359 |
|
| 2005 |
Noonan K, Matsui W, Serafini P, Carbley R, Tan G, Khalili J, Bonyhadi M, Levitsky H, Whartenby K, Borrello I. Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors. Cancer Research. 65: 2026-34. PMID 15753403 DOI: 10.1158/0008-5472.Can-04-3337 |
0.453 |
|
| 2005 |
Lin TL, Matsui W, Vala MS, Brennan S, Smith BD, Jones RJ. Anti-Leukemic Effect of Maintenance Chemotherapy Is Mediated by Induction of Differentiation. Blood. 106: 865-865. DOI: 10.1182/Blood.V106.11.865.865 |
0.413 |
|
| 2004 |
Jones RJ, Matsui WH, Smith BD. Cancer stem cells: are we missing the target? Journal of the National Cancer Institute. 96: 583-5. PMID 15100335 DOI: 10.1093/jnci/djh095 |
0.349 |
|
| 2004 |
Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI, Jones RJ. Characterization of clonogenic multiple myeloma cells. Blood. 103: 2332-6. PMID 14630803 DOI: 10.1182/Blood-2003-09-3064 |
0.314 |
|
| 2004 |
Matsui W, Huff CA, Wang Q, Barber JP, Smith BD, Jones RJ. Multiple Myeloma Stem Cells and Plasma Cells Display Distinct Drug Sensitivities. Blood. 104: 2476-2476. DOI: 10.1182/Blood.V104.11.2476.2476 |
0.422 |
|
| 2004 |
Matsui W, Angstreich GR, Vala MS, Barber JP, Hawkins AL, Griffin CA, Huff CA, Smith BD, Jones RJ. Chronic Myeloid Leukemia Stem Cells and Their Differentiated Progeny Display Divergent Drug Sensitivities to Imatinib Mesylate and Interferon-Alpha. Blood. 104: 1996-1996. DOI: 10.1182/Blood.V104.11.1996.1996 |
0.446 |
|
| 2003 |
Matsui W, Huff CA, Vala M, Barber J, Smith BD, Jones RJ. Anti-tumour activity of interferon-alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiation. British Journal of Haematology. 121: 251-258. PMID 12694246 DOI: 10.1046/J.1365-2141.2003.04255.X |
0.402 |
|
| Show low-probability matches. |